MEDICAL ASIAMEDICAL PLATFORM
한국어English中文日本語РусскийالعربيةEspañolМонголBahasa Indonesia

Information compiled by Medical Asia from public sources.

childhood cancer

Pediatric Cancer Care

PART I

Information items

01Institutional capabilities and essential infrastructure

Pediatric hematology-oncology, pediatric surgery, neurosurgery, orthopedic surgery, thoracic surgery, radiation oncology, pediatric imaging, pathology, genetics, transplant/cell therapy, pediatric infectious disease, ICU, anesthesia, rehabilitation, and mental health teams are necessary. Must have pediatric sterile wards, collection/processing of hematopoietic stem cells, 24-hour transfusion and intensive care, pediatric-dedicated surgery and anesthesia, hospital school, and survivor clinic.

02System capabilities and collaborative-care structure

Age- and body surface area-based treatment, molecular risk and MRD evaluation, emergency response for infection and tumor lysis, multidisciplinary surgical planning, donor search for transplantation and CAR-T toxicity management, pain and palliative care, and long-term follow-up for growth, endocrine, cardiac, renal, hearing, neurocognitive, fertility, and school/social reintegration are key.

03Recognition unit

Pediatric and adolescent cancer center, pediatric hematology-oncology center, recognizes multidisciplinary teams permanently connected within children's hospitals for transplant/cell therapy teams or management of blood cancer, solid tumors, surgery, rehabilitation, and survivors.

04Evidence and verification criteria

Use the international pediatric cancer classification from national cancer registry statistics, pediatric hematology-oncology and brain tumor guidelines, and official hospital pediatric cancer, transplant, and cure pages. Adult cancer outcomes are not used as substitutes, and treatment volume and survival rates are only used when age, disease, period, and denominators are separated.

05Currency status

Source currency has been confirmed; official verification is in progress.

06SEO and AI search architecture

Pediatric cancer center, pediatric leukemia hematopoietic stem cell transplantation, pediatric cancer CAR-T, pediatric brain tumor, pediatric sarcoma, childhood cancer survivor clinic, hospital school, pediatric cancer center Korea, childhood cancer Korea.

PART II

Detailed information item

01Definition of specialist medical care and domestic and international clinical statistics (Definition & Epidemiological Context)

Pediatric cancer occurs in a growing body, so its disease distribution, drug metabolism, and late complications differ from adult cancers. Among 830 newly diagnosed pediatric cancer cases aged 0–14 in Korea in 2023, 280 cases were leukemia, accounting for 33.7%. Along with improved cure rates, a system that tracks growth, endocrine, cardiopulmonary, neurocognitive outcomes, fertility, and secondary cancers for decades becomes part of the treatment.

02Patient problem and clinical entry point (Patient Problem Layer)

Persistent fever·pallor·bruising·bone pain, unexplained lymph node/abdominal masses, morning headache·vomiting, gait·visual abnormalities, weight loss are key entry points. Dyspnea, bleeding, decreased consciousness, tumor lysis, leukocytosis, spinal cord compression·increased intracranial pressure require immediate response from pediatric ICU·surgery·hematology-oncology teams.

03Precision Diagnostics and Functional Evaluation System (Diagnostics & Functional Evaluation)

Blood, bone marrow, flow cytometry, cytogenetics, molecular tests, histopathology, and pediatric protocol MRI, CT, and nuclear medicine tests are conducted. Before treatment, heart, kidney, liver, hearing, endocrine, growth, neurocognitive function, fertility, and infection status are assessed, and MRD, imaging, and tumor markers are tracked according to disease.

04Treatment Methods and Timeline-based Care Pathway

Step 1: Rapid confirmation and risk classification → identify disease, molecular type, stage, and emergency complications.

Phase 2: Pediatric MDT plan → Determines chemotherapy, surgery, radiation, transplantation, CAR-T, and organ function preservation.

Stage 3: Intensive treatment → Treat under pediatric aseptic, ICU, transfusion, and infection protocols.

Stage 4: Long-term management for cured patients → track growth, organ function, cognition, fertility, education, psychological status, secondary cancers, and social reintegration.

05Institutions providing specialized pediatric oncology care and multidisciplinary directory

Seoul

Region not confirmed

This page is public information based on official sources and administrator verification, and does not constitute medical advice or guarantee the excellence of a specific institution or specialist.